Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target

Figure 5

Methylation of Wnt antagonists and DNMTs expression in AML cells. A, MSP analysis. MSP was performed using previously published primer pairs as described in Methods. M, methylated reaction; U, unmethylated reaction; pos, positive control, neg, negative control. The PCR product for the M reaction was 158 bp long and that for the unmethylated reaction was 165 bp long; MSP, methylation-specific polymerase chain reaction. B, Expression of DNMT3A and DNMT3B in AML cell lines. Expression of DNMT3A and 3B were assayed by a standard western blot method in AML cells without treatment as the control group and AML cells with the treatment of DAC for 24 h, 48 h, and 72 h, respectively.

Back to article page